Adam Douglass was awarded a new R01 from the National Institute of Neurological Disorders and Stroke (NINDS) for the project: "Cellular and circuit mechanisms enabling oxytocinergic control of pain defense."
Adam Douglass was awarded a new R01 from the National Institute of Neurological Disorders and Stroke (NINDS) for the project: "Cellular and circuit mechanisms enabling oxytocinergic control of pain defense."